Aggregation formation in the polyglutamine diseases: protection at a cost?
about
The sodium leak channel, NALCN, in health and diseaseBeyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1Motor Dysfunctions and Neuropathology in Mouse Models of Spinocerebellar Ataxia Type 2: A Comprehensive ReviewPoly(Q) Expansions in ATXN7 Affect Solubility but Not Activity of the SAGA Deubiquitinating ModuleThe aggregation and inheritance of damaged proteins determines cell fate during mitosis.A knockin mouse model of spinocerebellar ataxia type 3 exhibits prominent aggregate pathology and aberrant splicing of the disease gene transcript.Polyglutamine- and temperature-dependent conformational rigidity in mutant huntingtin revealed by immunoassays and circular dichroism spectroscopyNemo-like kinase is a novel regulator of spinal and bulbar muscular atrophy.Enhanced molecular mobility of ordinarily structured regions drives polyglutamine diseaseC9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins.Potential therapeutic targets in polyglutamine-mediated diseases.Nanoparticulate strategies for the treatment of polyglutamine diseases by halting the protein aggregation process.Mutation-dependent aggregation and toxicity in a Drosophila model for UBQLN2-associated ALS.Autophagy mediates SUMO-induced degradation of a polyglutamine protein ataxin-3
P2860
Q26851725-1D5A59D3-5200-43EC-83B6-740ABC818A65Q27008548-2F81817B-6A30-4554-B273-AB3C43491FA0Q28076174-75FB3D96-DB20-4C39-A1D5-63C52549A2DEQ30300394-DA73CDA3-5A6E-4E59-9EA5-55F432232E02Q33578623-46AE8094-38AB-470D-9226-60768B5973F4Q35063135-7773581D-C10C-4AD9-8A4D-9C8B73CF5AA9Q35479250-059AEF03-8F3E-4E88-91A4-2EDB001EF7AEQ36081124-DBA00F5E-C6CB-4A07-83B8-5DE5C9105A89Q36115804-CF984227-5203-4F78-99FA-A06D9CF276DBQ37476206-F891AAA4-36AA-4562-8F8C-9CC626A5018AQ38246221-02801E5E-75B9-4D27-B13B-5673F2865707Q39112084-397B563C-FCA1-402D-BE32-53656B694304Q46257041-B5136F9A-76D4-41BC-AC39-91D8AFD2F801Q58133853-A6C5FAB2-C2F4-4072-88FF-89688648DE9B
P2860
Aggregation formation in the polyglutamine diseases: protection at a cost?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aggregation formation in the polyglutamine diseases: protection at a cost?
@en
Aggregation formation in the polyglutamine diseases: protection at a cost?
@nl
type
label
Aggregation formation in the polyglutamine diseases: protection at a cost?
@en
Aggregation formation in the polyglutamine diseases: protection at a cost?
@nl
prefLabel
Aggregation formation in the polyglutamine diseases: protection at a cost?
@en
Aggregation formation in the polyglutamine diseases: protection at a cost?
@nl
P2860
P1433
P1476
Aggregation formation in the polyglutamine diseases: protection at a cost?
@en
P2093
Janghoo Lim
Tiffany W Todd
P2860
P2888
P304
P356
10.1007/S10059-013-0167-X
P577
2013-06-19T00:00:00Z